As of 2025-05-31, the Intrinsic Value of Rexnord Corp (RXN) is 62.61 USD. This RXN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 64.92 USD, the upside of Rexnord Corp is -3.60%.
The range of the Intrinsic Value is 41.57 - 121.14 USD
Based on its market price of 64.92 USD and our intrinsic valuation, Rexnord Corp (RXN) is overvalued by 3.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 41.57 - 121.14 | 62.61 | -3.6% |
| DCF (Growth 10y) | 58.30 - 158.53 | 84.99 | 30.9% |
| DCF (EBITDA 5y) | 44.27 - 72.31 | 60.00 | -7.6% |
| DCF (EBITDA 10y) | 60.65 - 100.52 | 81.42 | 25.4% |
| Fair Value | 9.09 - 9.09 | 9.09 | -85.99% |
| P/E | 37.66 - 48.87 | 43.63 | -32.8% |
| EV/EBITDA | 32.59 - 53.31 | 45.64 | -29.7% |
| EPV | 17.68 - 25.73 | 21.70 | -66.6% |
| DDM - Stable | 14.87 - 48.35 | 31.61 | -51.3% |
| DDM - Multi | 32.41 - 81.37 | 46.30 | -28.7% |
| Market Cap (mil) | 7,863.37 |
| Beta | 1.40 |
| Outstanding shares (mil) | 121.12 |
| Enterprise Value (mil) | 8,664.57 |
| Market risk premium | 4.24% |
| Cost of Equity | 9.58% |
| Cost of Debt | 4.33% |
| WACC | 8.76% |